下颌前徙术治疗阻塞性睡眠呼吸暂停的远期疗效:一项Meta分析
该Meta分析系统检索截至2018年7月26日的国际文献,纳入6项研究共120例患者,评估下颌前徙术(MMA)治疗阻塞性睡眠呼吸暂停(OSA)的中期、长期和超长期疗效。结果显示各随访期呼吸暂停低通气指数(AHI)、嗜睡和最低血氧饱和度均有改善,但超长期平均AHI回升至中度OSA水平。
要点
- MMA治疗后中期、长期和超长期AHI均较术前降低,但超长期平均AHI回升至中度OSA范围。
- 嗜睡改善在所有随访期均得以维持,最低血氧饱和度改善在长期得以维持。
- 共筛查445项研究,最终纳入6项研究共120例患者。
核心结论
- 当前国际文献显示,接受MMA治疗的OSA患者在长期随访中AHI、嗜睡和最低血氧饱和度改善得以维持,但超长期平均AHI回升至中度OSA水平。
- 无法做出确定性推广,需要提供中期、长期和超长期个体患者数据的进一步研究。
研究设计与样本
- 系统综述与Meta分析,由三位作者系统检索截至2018年7月26日的国际文献。
- 数据来源包括Cochrane Library、Google Scholar、Embase、Cumulative Index to Nursing and Allied Health及PubMed/MEDLINE。
- 共筛查445项研究,6项符合标准,纳入120例患者。
主要发现
- 中期(1至<4年)31例患者AHI从术前平均48.3次/小时(95%CI 42.1-54.5)降至8.4(95%CI 5.6-11.2)。
- 长期(4至<8年)54例患者AHI从术前平均65.8次/小时(95%CI 58.8-72.8)降至7.7(95%CI 5.9-9.5)。
- 超长期(≥8年)35例患者AHI从术前平均53.2次/小时(95%CI 45-61.4)降至23.1(95%CI 16.3-29.9)。
- 嗜睡改善在所有随访期均得以维持,最低血氧饱和度改善在长期得以维持。
局限性
- 无法做出确定性推广,需要提供中期、长期和超长期个体患者数据的进一步研究。
- 超长期平均AHI回升至中度OSA水平。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To examine outcomes in the intermediate term (1 to <4 years), long term (4 to <8 years), and very long term (≥8 years) for maxillomandibular advancement (MMA) as treatment for obstructive sleep apnea (OSA). DATA SOURCES: The Cochrane Library, Google Scholar, Embase, Cumulative Index to Nursing and Allied Health, and PubMed/MEDLINE. REVIEW METHODS: Three authors systematically reviewed the international literature through July 26, 2018. RESULTS: A total of 445 studies were screened, and 6 met criteria (120 patients). Thirty-one patients showed a reduction in apnea-hypopnea index (AHI) from a mean 48.3 events/h (95% CI, 42.1-54.5) pre-MMA to 8.4 (95% CI 5.6, 11.2) in the intermediate term. Fifty-four patients showed a reduction in AHI from a mean 65.8 events/h (95% CI, 58.8-72.8) pre-MMA to 7.7 (95% CI 5.9, 9.5) in the long term. Thirty-five showed a reduction in AHI from a mean 53.2 events/h (95% CI 45, 61.4) pre-MMA to 23.1 (95% CI 16.3, 29.9) in the very long term. Improvement in sleepiness was maintained at all follow-up periods. Lowest oxygen saturation improvement was maintained in the long term. CONCLUSION: The current international literature shows that patients with OSA who were treated with MMA maintained improvements in AHI, sleepiness, and lowest oxygen saturation in the long term; however, the mean AHI increased to moderate OSA in the very long term. Definitive generalizations cannot be made, and additional research providing individual patient data for the intermediate term, long term, and very long term is needed.
引用
- Camacho M, Noller MW, Del Do M, et al. Long-term Results for Maxillomandibular Advancement to Treat Obstructive Sleep Apnea: A Meta-analysis. Otolaryngol Head Neck Surg. 2019. PMID: 30598047. doi:10.1177/0194599818815158
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。